In Veritas Medical Diagnostics, Inc.
OTC: IVME0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- G. T. Cooper
- Employees
- 7
- Headquarters
- Inverness, United Kingdom
- IPO year
- 2004
- Market cap
- $60.2K
Loading IVME…
Loading profile data…Frequently asked questions about IVME
What does In Veritas Medical Diagnostics, Inc. (IVME) do?
In Veritas Medical Diagnostics, Inc. (IVME) is a company currently in its development phase, dedicated to researching and creating advanced medical devices for point-of-care diagnostics. Their leading product is a prothrombin monitor, which assesses blood coagulation in patients at risk of cardiovascular diseases and strokes. The company is also...
Where does IVME trade?
In Veritas Medical Diagnostics, Inc. (IVME) trades on the Other OTC.
What sector is IVME in?
In Veritas Medical Diagnostics, Inc. (IVME) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of In Veritas Medical Diagnostics, Inc.?
G. T. Cooper is the chief executive officer of In Veritas Medical Diagnostics, Inc. (IVME).
Where is In Veritas Medical Diagnostics, Inc. headquartered?
In Veritas Medical Diagnostics, Inc. is headquartered in United Kingdom.
Does IVME pay a dividend?
In Veritas Medical Diagnostics, Inc. (IVME) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVME go public?
In Veritas Medical Diagnostics, Inc. (IVME) completed its initial public offering in 2004.